Oncternal Therapeutics, Inc.
Total Funding
$18.4 Million
Total Rounds
1
First Raise
Feb 22, 2017
Latest Raise
Feb 22, 2017
Organization Chart
Founders and leadership hierarchy for this company.
Contact details require Sales or Enterprise
All Funding Rounds
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 2/22/2017 | Series B | $18.4 Million | James Breitmeyer, M.D., Ph.D. |
Company Performance Metrics
Premium Feature
Upgrade to Premium to view Capital Momentum Score and performance metrics